• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞质醛糖代谢促进肝硬化向肝癌发生的进展。

Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.

机构信息

Departments of Medicine, State University of New York, Norton College of Medicine, Syracuse, NY, USA.

Departments of Biochemistry and Molecular Biology, State University of New York, Norton College of Medicine, Syracuse, NY, USA.

出版信息

Nat Metab. 2023 Jan;5(1):41-60. doi: 10.1038/s42255-022-00711-9. Epub 2023 Jan 19.

DOI:10.1038/s42255-022-00711-9
PMID:36658399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9892301/
Abstract

Oxidative stress modulates carcinogenesis in the liver; however, direct evidence for metabolic control of oxidative stress during pathogenesis, particularly, of progression from cirrhosis to hepatocellular carcinoma (HCC), has been lacking. Deficiency of transaldolase (TAL), a rate-limiting enzyme of the non-oxidative branch of the pentose phosphate pathway (PPP), restricts growth and predisposes to cirrhosis and HCC in mice and humans. Here, we show that mitochondrial oxidative stress and progression from cirrhosis to HCC and acetaminophen-induced liver necrosis are critically dependent on NADPH depletion and polyol buildup by aldose reductase (AR), while this enzyme protects from carbon trapping in the PPP and growth restriction in TAL deficiency. Both TAL and AR are confined to the cytosol; however, their inactivation distorts mitochondrial redox homeostasis in opposite directions. The results suggest that AR acts as a rheostat of carbon recycling and NADPH output of the PPP with broad implications for disease progression from cirrhosis to HCC.

摘要

氧化应激调节肝脏的癌变;然而,在发病机制中,特别是在从肝硬化到肝细胞癌(HCC)的进展过程中,代谢控制氧化应激的直接证据一直缺乏。转醛醇酶(TAL)是戊糖磷酸途径(PPP)非氧化分支的限速酶,其缺乏会限制生长,并导致人和小鼠发生肝硬化和 HCC。在这里,我们表明,线粒体氧化应激以及从肝硬化到 HCC 的进展和对乙酰氨基酚引起的肝坏死,严重依赖于醛糖还原酶(AR)的 NADPH 耗竭和多元醇的积累,而这种酶可以防止 PPP 中的碳捕获和 TAL 缺乏引起的生长受限。TAL 和 AR 都局限于细胞质;然而,它们的失活以相反的方向扭曲了线粒体氧化还原稳态。结果表明,AR 作为 PPP 的碳回收和 NADPH 输出的变阻器发挥作用,对从肝硬化到 HCC 的疾病进展具有广泛的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/76ca9c010fd7/nihms-1857993-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/fdca2e297748/nihms-1857993-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/a71ef1e07462/nihms-1857993-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/2769f20d78a1/nihms-1857993-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/921c547b9b47/nihms-1857993-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/4955f397458f/nihms-1857993-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/c234f192f084/nihms-1857993-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/4723c0c35a46/nihms-1857993-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/3bf20d0b2927/nihms-1857993-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/94fcfcb42f0f/nihms-1857993-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/3f46f96734b0/nihms-1857993-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/4ae480acba78/nihms-1857993-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/002fa4d75685/nihms-1857993-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/e2a8f56f17c0/nihms-1857993-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/76ca9c010fd7/nihms-1857993-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/fdca2e297748/nihms-1857993-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/a71ef1e07462/nihms-1857993-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/2769f20d78a1/nihms-1857993-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/921c547b9b47/nihms-1857993-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/4955f397458f/nihms-1857993-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/c234f192f084/nihms-1857993-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/4723c0c35a46/nihms-1857993-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/3bf20d0b2927/nihms-1857993-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/94fcfcb42f0f/nihms-1857993-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/3f46f96734b0/nihms-1857993-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/4ae480acba78/nihms-1857993-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/002fa4d75685/nihms-1857993-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/e2a8f56f17c0/nihms-1857993-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/872e/9892301/76ca9c010fd7/nihms-1857993-f0007.jpg

相似文献

1
Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis.细胞质醛糖代谢促进肝硬化向肝癌发生的进展。
Nat Metab. 2023 Jan;5(1):41-60. doi: 10.1038/s42255-022-00711-9. Epub 2023 Jan 19.
2
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.转醛醇酶缺乏导致的自身免疫性疾病相关性肝硬化的发病机制与 mTOR 依赖性 PON1 分泌缺失和抗磷脂自身抗体产生有关。
J Autoimmun. 2023 Nov;140:103112. doi: 10.1016/j.jaut.2023.103112. Epub 2023 Sep 22.
3
Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.翻译:对乙酰氨基酚诱导肝衰竭患者中 transaldolase 单倍体不足。
J Inherit Metab Dis. 2020 May;43(3):496-506. doi: 10.1002/jimd.12197. Epub 2020 Jan 1.
4
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.N-乙酰半胱氨酸对转醛醇酶缺陷小鼠肝癌发生的预防作用及对乙酰氨基酚诱导的肝衰竭易感性增加
J Clin Invest. 2009 Jun;119(6):1546-57. doi: 10.1172/JCI35722. Epub 2009 May 11.
5
Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.通过转醛醇酶,氧化应激、炎症和致癌作用可通过戊糖磷酸途径得到控制。
Trends Mol Med. 2011 Jul;17(7):395-403. doi: 10.1016/j.molmed.2011.01.014. Epub 2011 Mar 2.
6
The pathogenesis of transaldolase deficiency.转醛醇酶缺乏症的发病机制。
IUBMB Life. 2007 Jun;59(6):365-73. doi: 10.1080/15216540701387188.
7
Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.转醛醇酶缺乏会影响磷酸戊糖途径、线粒体稳态和凋亡信号处理。
Biochem J. 2008 Oct 1;415(1):123-34. doi: 10.1042/BJ20080722.
8
Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma.肝硬化:肝癌的一个有争议的危险因素。
Trends Cancer. 2021 Jan;7(1):29-36. doi: 10.1016/j.trecan.2020.08.005. Epub 2020 Sep 8.
9
Implication of the Hedgehog pathway in hepatocellular carcinoma.刺猬信号通路在肝细胞癌中的作用
World J Gastroenterol. 2017 Jun 28;23(24):4330-4340. doi: 10.3748/wjg.v23.i24.4330.
10
The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.转化生长因子-α在肝硬化、发育异常结节及肝细胞癌中的表达:70例免疫组织化学研究
Am J Surg Pathol. 2007 May;31(5):681-9. doi: 10.1097/PAS.0b013e31802ff7aa.

引用本文的文献

1
Stress granules shape metabolic reprogramming and drug resistance.应激颗粒塑造代谢重编程和耐药性。
Nat Cancer. 2025 Jun 4. doi: 10.1038/s43018-024-00886-y.
2
Serum Erythritol and Risk of Overall and Cause-Specific Mortality in a Cohort of Men.血清赤藓糖醇与男性队列的全因和死因特异性死亡率的关系。
Nutrients. 2024 Sep 14;16(18):3099. doi: 10.3390/nu16183099.
3
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis.B细胞和T细胞:(仍然)是自身免疫性肝炎中的主要协调者。

本文引用的文献

1
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.醛缩酶B通过抑制葡萄糖-6-磷酸脱氢酶(G6PD)和磷酸戊糖途径来抑制肝细胞癌发生。
Nat Cancer. 2020 Jul;1(7):735-747. doi: 10.1038/s43018-020-0086-7. Epub 2020 Jul 6.
2
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma.糖酵解肿瘤起始细胞的一个独特亚群驱动鳞状细胞癌。
Nat Metab. 2021 Feb;3(2):182-195. doi: 10.1038/s42255-021-00350-6. Epub 2021 Feb 22.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Autoimmun Rev. 2024 Jul-Aug;23(7-8):103591. doi: 10.1016/j.autrev.2024.103591. Epub 2024 Aug 6.
4
Causality of metabolites and metabolic pathways on cholestatic liver diseases: a Mendelian randomization study.代谢物和代谢途径与胆汁淤积性肝病的因果关系:一项孟德尔随机化研究
Front Med (Lausanne). 2024 Jul 2;11:1395526. doi: 10.3389/fmed.2024.1395526. eCollection 2024.
5
The hepatocellular carcinoma risk in patients with HBV-related cirrhosis: a competing risk nomogram based on a 4-year retrospective cohort study.乙肝相关肝硬化患者的肝细胞癌风险:基于一项4年回顾性队列研究的竞争风险列线图
Front Oncol. 2024 May 16;14:1398968. doi: 10.3389/fonc.2024.1398968. eCollection 2024.
6
Redox Pathogenesis in Rheumatic Diseases.风湿性疾病中的氧化还原发病机制。
ACR Open Rheumatol. 2024 Jun;6(6):334-346. doi: 10.1002/acr2.11668. Epub 2024 Apr 25.
7
Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation.Rab4A 靶向内体运输通过线粒体自噬、CD98 表达和色氨酸敏感的 mTOR 激活来塑造 T 细胞中的促炎线粒体代谢。
Nat Commun. 2024 Mar 22;15(1):2598. doi: 10.1038/s41467-024-46441-2.
8
Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?在炎症性肿瘤微环境中重新编程调节性 T 细胞:它能成为免疫治疗的转折点吗?
Front Immunol. 2024 Feb 21;15:1345838. doi: 10.3389/fimmu.2024.1345838. eCollection 2024.
9
ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway.ZMIZ2通过LEF1介导的Wnt/β-连环蛋白信号通路激活促进肝细胞癌进展。
Exp Hematol Oncol. 2024 Jan 22;13(1):5. doi: 10.1186/s40164-024-00475-w.
10
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.衰老和氧化应激对代谢和神经系统疾病的影响:程序性细胞死亡和分子信号转导的串扰。
Front Immunol. 2023 Nov 8;14:1273570. doi: 10.3389/fimmu.2023.1273570. eCollection 2023.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences.高血清尿酸水平可能是肝细胞癌复发的一个危险因素。
Nutr Cancer. 2021;73(6):996-1003. doi: 10.1080/01635581.2020.1779758. Epub 2020 Jun 15.
5
Hyperhomocysteinemia-Induced Oxidative Stress Aggravates Renal Damage in Hypertensive Rats.高同型半胱氨酸血症诱导的氧化应激加重高血压大鼠的肾脏损伤。
Am J Hypertens. 2020 Dec 31;33(12):1127-1135. doi: 10.1093/ajh/hpaa086.
6
Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.翻译:对乙酰氨基酚诱导肝衰竭患者中 transaldolase 单倍体不足。
J Inherit Metab Dis. 2020 May;43(3):496-506. doi: 10.1002/jimd.12197. Epub 2020 Jan 1.
7
Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.转醛醇酶缺乏症的临床、生化和分子概述及内分泌功能评估:34 例患者的更新资料。
J Inherit Metab Dis. 2019 Jan;42(1):147-158. doi: 10.1002/jimd.12036.
8
Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.转醛醇酶缺乏症患者的对乙酰氨基酚表观毒性
JIMD Rep. 2019;44:9-15. doi: 10.1007/8904_2018_116. Epub 2018 Jun 20.
9
Metabolomics and Isotope Tracing.代谢组学和同位素示踪。
Cell. 2018 May 3;173(4):822-837. doi: 10.1016/j.cell.2018.03.055.
10
Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana.转酮醇酶缺失可引发墨西哥利什曼原虫前鞭毛体的严格代谢反应和无鞭毛体毒力丧失。
PLoS Pathog. 2018 Mar 19;14(3):e1006953. doi: 10.1371/journal.ppat.1006953. eCollection 2018 Mar.